Commonwealth Equity Services’s Caribou Biosciences CRBU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$84.3K Buy
47,908
+3,000
+7% +$5.93K ﹤0.01% 4268
2026
Q1
$85.3K Sell
44,908
-1,000
-2% -$1.72K ﹤0.01% 4154
2025
Q4
$73K Sell
45,908
-1,025
-2% -$2.15K ﹤0.01% 4145
2025
Q3
$109K Sell
46,933
-13,031
-22% -$24.6K ﹤0.01% 4076
2025
Q2
$76K Sell
59,964
-1,340
-2% -$1.32K ﹤0.01% 4104
2025
Q1
$56K Buy
61,304
+3,188
+5% +$4.14K ﹤0.01% 4054
2024
Q4
$92K Buy
58,116
+858
+1% +$1.73K ﹤0.01% 3923
2024
Q3
$112K Buy
57,258
+1,107
+2% +$2.27K ﹤0.01% 3843
2024
Q2
$92K Buy
56,151
+6,621
+13% +$21.2K ﹤0.01% 3824
2024
Q1
$255K Sell
49,530
-605
-1% -$3.73K ﹤0.01% 3422
2023
Q4
$287K Buy
50,135
+18,435
+58% +$91.1K ﹤0.01% 3216
2023
Q3
$152K Buy
31,700
+150
+0.5% +$931 ﹤0.01% 3474
2023
Q2
$134K Buy
31,550
+7,175
+29% +$32.2K ﹤0.01% 3519
2023
Q1
$129K Buy
24,375
+2,100
+9% +$13.1K ﹤0.01% 3439
2022
Q4
$139K Sell
22,275
-100
-0.4% -$890 ﹤0.01% 3344
2022
Q3
$236K Buy
22,375
+6,135
+38% +$57.2K ﹤0.01% 3027
2022
Q2
$88K Buy
+16,240
New +$124K ﹤0.01% 3397

Other funds holding CRBU

Commonwealth Equity Services's CRBU Position: Q2 2026 in Review

Commonwealth Equity Services increased its Caribou Biosciences (CRBU) stake by 6.7% in Q2 2026, buying an estimated $5.93K and bringing the position to 47,908 shares worth $84.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4268.

Commonwealth Equity Services first reported a position in CRBU in Q2 2022 and has held it in 17 quarters since. The position peaked at $287K in Q4 2023. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Commonwealth Equity Services held 47,908 shares of Caribou Biosciences worth $84.3K as of Q2 2026.
  • Commonwealth Equity Services bought 3,000 Caribou Biosciences shares in Q2 2026, an estimated $5.93K.
  • Caribou Biosciences made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4268 holding.
  • Commonwealth Equity Services first reported a position in Caribou Biosciences in Q2 2022 and has held it in 17 quarters since.
  • Commonwealth Equity Services's Caribou Biosciences position peaked at $287K in Q4 2023.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.